A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors
Clinical trial NCT07251166 · RECRUITING
Trial details
- NCT number
- NCT07251166
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2028-03-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.